Pharming (PHAR) EBIT (2020 - 2026)
Pharming (PHAR) reported EBIT of -$3.6 million for Q2 2026, compared with $3.81 million a year earlier.
Powered by 
Analysis
Pharming (PHAR) EBIT (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Pharming's EBIT came in at $7.3 million, up 706.8% year-over-year; for FY2025, it came in at $25.84 million.
- EBIT has a five-year compound annual growth rate of -19.4% (FY2020 to FY2025).
- By year, EBIT came in at -$15.3 million in FY2024, -$5.39 million in FY2023, $28.4 million in FY2022 and $13,080 in FY2021 (-100.0%).
- Five-year quarterly EBIT spans a low of -$19.43 million in Q2 2024 and a high of $17.8 million in Q2 2022.
- Year over year, EBIT gained in two of the last four quarters, with growth averaging 73.2%.
- The high point for year-over-year EBIT in five years was Q3 2025 (growth of 285.4%); the low point was Q4 2024 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$4.9 million (Q1 2026), $6.20 (Q4 2025) and $15.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Pharming | 738.17 Mn | -91.99 Mn | 141.47 Mn | -3.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.60 Mn |
| Mar 31, 2026 | -4.90 Mn |
| Dec 31, 2025 | 6.20 |
| Sep 30, 2025 | 15.80 Mn |
| Jun 30, 2025 | 3.81 Mn |
| Mar 31, 2025 | -7.00 Mn |
| Dec 31, 2024 | 6.70 |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | -19.43 Mn |
| Mar 31, 2024 | -16.30 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | -13.66 Mn |
| Dec 31, 2022 | -10.20 Mn |
| Sep 30, 2022 | 7.80 Mn |
| Jun 30, 2022 | 17.80 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | -14.63 Mn |
| Sep 30, 2021 | -1.68 Mn |
API Access
Pharming EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();